BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12883323)

  • 21. Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2.
    Qu C; Leung SW; Vanhoutte PM; Man RY
    J Pharmacol Exp Ther; 2010 Aug; 334(2):373-80. PubMed ID: 20444882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
    De Gennaro Colonna V; Fioretti S; Rigamonti A; Bonomo S; Manfredi B; Muller EE; Berti F; Rossoni G
    J Hypertens; 2006 Jan; 24(1):95-102. PubMed ID: 16331106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase inhibition reduces blood pressure elevation and vascular reactivity dysfunction caused by inhibition of nitric oxide synthase in rats.
    da Cunha V; Rossoni LV; Oliveira PA; Poton S; Pretti SC; Vassallo DV; Stefanon I
    Clin Exp Hypertens; 2000 Feb; 22(2):203-15. PubMed ID: 10744360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats.
    Pruefer D; Scalia R; Lefer AM
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2894-900. PubMed ID: 10591666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
    McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
    Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
    López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
    Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of chronic nitric oxide synthase inhibition in genetically hypertensive rats.
    Orange SJ; Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):488-93. PubMed ID: 10874504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
    Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
    Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelium-dependent vasorelaxation independent of nitric oxide and K(+) release in isolated renal arteries of rats.
    Jiang F; Dusting GJ
    Br J Pharmacol; 2001 Apr; 132(7):1558-64. PubMed ID: 11264250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of radiographic contrast media on endothelium derived nitric oxide-dependent renal vasodilatation.
    Morcos SK; Oldroyd S; Haylor J
    Br J Radiol; 1997 Feb; 70():154-9. PubMed ID: 9135441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise conditioning attenuates the hypertensive effects of nitric oxide synthase inhibitor in rat.
    Husain K
    Mol Cell Biochem; 2002 Feb; 231(1-2):129-37. PubMed ID: 11952154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroprotective effect of simvastatin against indomethacin-induced gastric ulcer in rats: role of nitric oxide and prostaglandins.
    Heeba GH; Hassan MK; Amin RS
    Eur J Pharmacol; 2009 Apr; 607(1-3):188-93. PubMed ID: 19217901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat.
    Rossoni G; Manfredi B; De Gennaro Colonna V; Berti M; Guazzi M; Berti F
    Br J Pharmacol; 2007 Mar; 150(5):567-76. PubMed ID: 17245365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed.
    McCulloch AI; Randall MD
    Br J Pharmacol; 1998 Apr; 123(8):1700-6. PubMed ID: 9605578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term vascular effects of Nomega-nitro-L-arginine methyl ester are not soley mediated by inhibition of endothelial nitric oxide synthesis in the rat mesenteric artery.
    Zhao H; Shimokawa H; Uragami-Harasawa L; Igarashi H; Takeshita A
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):554-66. PubMed ID: 10218725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
    Nagaoka T; Hein TW; Yoshida A; Kuo L
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of exercise training on resistance arteries in rats with chronic NOS inhibition.
    Kuru O; Sentürk UK; Koçer G; Ozdem S; Başkurt OK; Cetin A; Yeşilkaya A; Gündüz F
    J Appl Physiol (1985); 2009 Sep; 107(3):896-902. PubMed ID: 19498093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impairment of nitric oxide-mediated relaxations in anaesthetized autoperfused streptozotocin-induced diabetic rats.
    Angulo J; Rodríguez-Mañas L; Peiró C; Neira M; Marín J; Sánchez-Ferrer CF
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):529-37. PubMed ID: 9840421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats.
    Alvarez de Sotomayor M; Vega S; Mingorance C; Marhuenda E; Herrera MD
    Pharmacology; 2008; 82(2):89-96. PubMed ID: 18509252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
    Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.